Vasculitis & polymyalgia rheumatica

Coronary artery disease in Behçet’s syndrome: a coronary computed tomography angiography study

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

BS does not appear to accelerate atherosclerosis, in contrast to other systemic rheumatic diseases.

Study context

Population
Asymptomatic male Behçet's syndrome (BS) patients and matched male controls
Participants
178 vs 139
Exposure
Asymptomatic male BS patients vs matched male controls
  • BSn = 178
  • Controlsn = 139reference
Outcome
Coronary artery involvement on CCTA (stenosis, aneurysm, arteritis or occlusion)
Methodological detailsmatched controls, coronary CT angiography, coronary CT angiography (CCTA) images evaluated independently by two radiologists, excellent inter-observer agreement
  • Matched controls
  • Coronary CT angiography
  • CCTA images evaluated independently by two radiologists, excellent inter-observer agreement

Main finding

As reported in the abstract

Any coronary lesion prevalence

P = 0.694

Observational data: associations, not effects.

Further findings

OutcomeBSP value
Stenosis20.8%P = 0.286
Vasculitis-related lesions (aneurysm, arteritis, total occlusion)
Aneurysms5.1%
Arteritis4.0%
Total occlusions1.7%

Agatston calcium scores

Similar between BS patients and controls

Vasculitis-related lesions (aneurysm, arteritis, total occlusion)

Occurred only in BS patients

Predictors of any coronary lesion

Age, OR (95% CI 1.047-1.184, P < 0.001), independent predictor
1.113
Venous involvement, OR (95% CI 0.114-0.664, P = 0.004), protective association
0.275

Clinical risk stratification

Arterial and neurological involvement highest risk; venous involvement lowest risk

Original publication

Coronary artery disease in Behçet’s syndrome: a coronary computed tomography angiography study. Rheumatology (Oxford). Published 17 October 2025. doi:10.1093/rheumatology/keaf551

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.